Downloadable slides on individualizing perioperative treatment for patients with high-risk HR-positive and/or germline BRCA–mutated early-stage breast cancer.
Downloadable slides on leveraging immune checkpoint inhibitors for perioperative treatment of patients with early-stage triple-negative breast cancer.
Downloadable slides featuring expert perspectives on clinical challenges and controversies in the rapidly evolving management of early-stage breast cancer.
In this on-demand webcast from a live symposium, experts Heather McArthur, MD, MPH; Jennifer K. Litton, MD; and Rita Nanda, MD discuss the most up-to-date guidance on managing early-stage breast cancer.
Management of early-stage breast cancer is rapidly evolving with perioperative options now including abemaciclib, olaparib, and pembrolizumab. In this commentary, Heather McArthur, MD, MPH, shares key takeaways on the latest developments.